Full Text Journal Articles in
Journal Inflamm Bowel Dis

Advertisement

Find full text journal articles






Bringing to Light the Risk of Colorectal Cancer in Inflammatory Bowel Disease: Mucosal Glycosylation as a Key Player.

Eduarda Leite-Gomes, Ana M Dias, Catarina M Azevedo, Beatriz Santos-Pereira, Mariana Magalhães, Mónica Garrido, Rita Amorim, Paula Lago, Ricardo Marcos-Pinto, Salomé S Pinho,

Colitis-associated cancer is a major complication of inflammatory bowel disease remaining an important clinical challenge in terms of diagnosis, screening, and prognosis. Inflammation is a driving factor both in inflammatory bowel disease and cancer, but the mechanism underlying the transition from colon inflammation to cancer remains to be defined. Dysregulation ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.

Karin Cerna, Dana Duricova, Martin Lukas, Nadezda Machkova, Veronika Hruba, Katarina Mitrova, Kristyna Kubickova, Marta Kostrejova, Vladimir Teplan, Martin Vasatko, Kristyna Kastylova, Milan Lukas,

<h4>Background</h4>Patients with inflammatory bowel disease (IBD) on immune-modifying treatment could be at an increased risk for severe coronavirus disease 2019 (COVID-19); thus, data on the efficacy and safety of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines are essential. We conducted a prospective study of IBD patients vaccinated with BNT162b2, CX-024414, ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study.

Yuhao Sun, Jiawei Geng, Xuejie Chen, Hui Chen, Xiaoyan Wang, Jie Chen, Xue Li, Therese Hesketh,

<h4>Background</h4>The association between inflammatory bowel disease (IBD) and dementia remains uncertain. We aim to investigate whether IBD is associated with higher dementia risk.<h4>Methods</h4>Using multivariable Cox regression models, we analyzed the onset of all-cause dementia among 497,775 participants, including 5778 IBD patients in the UK Biobank as primary analysis. In secondary ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.

David M Alvarado, Juhee Son, Larissa B Thackray, Maria Florencia Gomez Castro, Sarada Prasad, Xueyang Cui, Naomi M Sonnek, Michael S Diamond, Siyuan Ding, Matthew A Ciorba,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized Trial.

Wenhui Zhang, Astrid Scalori, Franklin Fuh, Jacqueline McBride, Gaohong She, Jaroslaw Kierkus, Bartosz Korczowksi, Regan Li, Mariam Abouhossein, Alysha Kadva, K T Park, Meina Tao Tang,

<h4>Background</h4>Etrolizumab, a humanized anti-β7 antibody, has not been studied in children. Here, we evaluate the pharmacokinetics, pharmacodynamics, and safety of etrolizumab in children with inflammatory bowel disease.<h4>Methods</h4>Patients age 4 to 17 years with moderately to severely active ulcerative colitis or Crohn's disease were randomized 1:1 to receive 1.5mg/kg of etrolizumab ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis.

Athanasios Desalermos, Michael Pimienta, Markos Kalligeros, Fadi Shehadeh, Leonidas Diamantopoulos, George Karamanolis, Freddy Caldera, Francis A Farraye,

<h4>Background</h4>Patients with inflammatory bowel disease (IBD) have low vaccination rates for vaccine-preventable diseases. Fear of adverse reactions (AEs) appear to negatively affect vaccination efforts. We aimed to systemically review the risks for AEs following immunization for patients with IBD.<h4>Methods</h4>We searched PubMed and Embase until April 15, 2020, for studies evaluating ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.

Simon Kjeldsen, Jan Nielsen, Bente Mertz Nørgård, Jens Kjeldsen,

<h4>Background</h4>We assessed whether 5-aminosalicylic acid (5-ASA), as treatment for inflammatory bowel disease (IBD), was associated with an increase in hospitalization for coronavirus disease 2019 and adverse in-hospital outcomes.<h4>Methods</h4>This was a Danish nationwide register study. The study population consisted of all patients with an IBD diagnosis between March 1, 2010, and ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Primary Versus Staged Reconstruction and Risk of Surgical Failure in Patients With Ulcerative Colitis: a Nation-wide Cohort Study.

Karin Westberg, Ola Olén, Jonas Söderling, Jonas Bengtsson, Jonas F Ludvigsson, Åsa H Everhov, Pär Myrelid, Caroline Nordenvall,

<h4>Background</h4>Restorative surgery after colectomy due to ulcerative colitis (UC) may be performed simultaneously with colectomy (primary) or as a staged procedure. Risk factors for failure after restorative surgery are not fully explored. This study aimed to compare the risk of failure after primary and staged reconstruction.<h4>Methods</h4>This is a national register-based ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



A Rare Case of Hearing Loss in a Patient With Ulcerative Colitis.

Chhagan Lal Birda, Ashish Agarwal, Amit Goyal,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".

Andrea Costantino, Daniele Noviello, Claudio Costantino, Maurizio Vecchi, Flavio Caprioli,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Strategies to Distinguish Perianal Fistulas Related to Crohn's Disease From Cryptoglandular Disease: Systematic Review With Meta-Analysis.

Kevin Chin Koon Siw, Jake Engel, Samantha Visva, Ranjeeta Mallick, Ailsa Hart, Anthony de Buck van Overstraeten, Jeffrey D McCurdy,

<h4>Background</h4>Management of perianal fistulas differs based on fistula type. We aimed to assess the ability of diagnostic strategies to differentiate between Crohn's disease (CD) and cryptoglandular disease (CGD) in patients with perianal fistulas.<h4>Methods</h4>We performed a diagnostic accuracy systematic review and meta-analysis. A systematic search of electronic databases was performed from ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.

Lester Tsai, Jeffrey D McCurdy, Christopher Ma, Vipul Jairath, Siddharth Singh,

<h4>Background and aims</h4>Perianal Crohn's disease (pCD) is a potentially severe phenotype of CD. We conducted a systematic review with meta-analysis to estimate cumulative incidence, risk factors, and outcomes of pCD in population-based cohort studies.<h4>Methods</h4>Through a systematic literature review through March 1, 2021, we identified population-based inception cohort studies reporting cumulative ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Multifaceted Secukinumab-induced Colitis.

Alexandros G Sykaras, Evangelia Margellou, Natalia G Vallianou, Fotis Panagopoulos, Eleni Geladari, Ioannis Alevizakis, Christina Magkou,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Characterization of Mycophenolate Mofetil Gastrointestinal Toxicity and Risk Factors for Severe Disease and Poor Prognosis.

Sumona Bhattacharya, Gianna Stoleru, Preet Patel, Ameer Abutaleb, Kristen Stashek, Raymond K Cross,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Corrigendum to: Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies.

Bindu Chandrasekharan, Darra Boyer, Joshua A Owens, Alexandra A Wolfarth, Bejan J Saeedi, Tanvi Dhere, Heba Iskandar, Andrew S Neish,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Reply to Response to "Strongyloides stercoralis in Acute Severe Ulcerative Colitis-A Triggering Nuisance or an Opportunistic Bystander?" by Hokama et al.

Anurag Sachan, Anupam Kumar Singh,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Crohn's Disease Complicated by an Ileo-urachal Fistula.

Qiu-Feng Zhao, Song Wang,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study.

Jurij Hanzel, Erwin Dreesen, Séverine Vermeire, Mark Löwenberg, Frank Hoentjen, Peter Bossuyt, Esmé Clasquin, Filip J Baert, Geert R D'Haens, Ron Mathôt,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn's Disease.

Jurij Hanzel, Vipul Jairath, Peter De Cruz, Leonardo Guizzetti, Lisa M Shackelton, Peter Bossuyt, Marjolijn Duijvestein, Parambir S Dulai, Johannes Grossmann, Robert P Hirten, Reena Khanna, Julian Panes, Laurent Peyrin-Biroulet, Miguel Regueiro, David T Rubin, Siddharth Singh, Ryan W Stidham, William J Sandborn, Brian G Feagan, Geert R D'Haens, Christopher Ma,

<h4>Background</h4>The lack of standardized methods for clinical trial design and disease activity assessment has contributed to an absence of approved medical therapies for the prevention of postoperative Crohn's disease (CD). We developed recommendations for regulatory trial design for this indication and for endoscopic assessment of postoperative CD activity.<h4>Methods</h4>An international panel ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Mesalamine-Induced Perimyocarditis: Rare Adverse Event in a Patient With Acute Severe Ulcerative Colitis.

Anuraag Jena, Anupam Kumar Singh, Bikkina Venkat Siddharda, Prashant Panda, Vishal Sharma,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.

Bingqing Yu, Chuangzhen Lin, Yuping Yang, Ya-Feng Yang, Biao Nie,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Translating Results from VARSITY to Real World: Adalimumab vs Vedolizumab as First-line Biological in Moderate to Severe IBD.

Annick Moens, Bram Verstockt, Dahham Alsoud, João Sabino, Marc Ferrante, Séverine Vermeire,

<h4>Background</h4>Selecting a first-line therapy remains challenging in IBD. Adalimumab (ADM) and vedolizumab (VDZ) effectively lead to endoscopic remission in moderate to severe IBD. The VARSITY trial showed superiority of VDZ over ADM in ulcerative colitis (UC) regarding clinical remission and endoscopic improvement at week 52. We explored these results in ... Read more >>

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Did You Get My Message? Trends and Predictors of Inflammatory Bowel Disease Patient-to-Provider Electronic Messaging.

Megan K Lutz, Lindsay A Matthews, Wen-Jan Tuan, Freddy Caldera, Sumona Saha,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells.

Karam Matlub Sørensen, Charlotte Harken Jensen, Søren Paludan Sheikh, Niels Qvist, Jens Ahm Sørensen,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy.

Ralley Prentice, Emily K Wright, Emma Flanagan, Alyson L Ross, Sally J Bell,

Inflamm Bowel Dis (Inflammatory bowel diseases)
[2021, :]

Cited: 0 times

View full text PDF listing >>



Advertisement


Disclaimer

0.9612 s